5-{[4-(tetrahydro-2H-pyran-2-yloxy)cyclohexyl]oxy}-1H-indazole → 5-(Pyrrolidin-3-yloxy)-1H-indazole

HRID 1269810

Reaktionsgleichung

Reaktionsgleichung von HRID 1269810
O1CCCCC1OC1C[CH2:12][CH:11]([O:14][C:15]2[CH:16]=[C:17]3[C:21](=[CH:22][CH:23]=2)[NH:20][N:19]=[CH:18]3)[CH2:10][CH2:9]1.[NH:24]1C2C(=CC(OC3CCC(O)CC3)=CC=2)C=N1>>[NH:24]1[CH2:9][CH2:10][CH:11]([O:14][C:15]2[CH:16]=[C:17]3[C:21](=[CH:22][CH:23]=2)[NH:20][N:19]=[CH:18]3)[CH2:12]1

Komponenten

3

Edukt 2

HCID 184472075-{[4-(tetrahydro-2H-pyran-2-yloxy)cyclohexyl]oxy}-1H-indazoleHCID 229333694-(1H-indazol-5-yloxy)cyclohexanol

Produkt 1

HCID 229333985-(Pyrrolidin-3-yloxy)-1H-indazole

Versuchsvorschrift

The following compound of Example 379 was synthesized by carrying out reactions according to the methods described in Example 372, (b) and Example 377 except for using the tert-butyl 4-hydroxyazepane-1-carboxylate obtained in Example 322, (c), as a reagent.

Quellen und Nachweise

ORD-Eintrag
ord-d951db50d9cf45e898ab537e61d46b0e
Quelldatensatz
uspto-grants-2007_04
Patentnummer
US07199147B2

Verknüpfte Notizen

Wird geladen…